
BIOPHEN™ FVIII:C Chromogenic Assay (2 × 6 mL)
Price:
$924.00
Product DescriptionChromogenic assay for Factor VIII coagulant activity (FVIII:C) in citrated human plasma or therapeutic FVIII concentrates. Uses human Factor IX and Factor X reagents — validated for Emicizumab (Hemlibra®) "FVIII-like" activity measurement. CE-IVD.
High-volume 2 × 6 mL format for hemophilia treatment centers. CE-IVD. Product Characteristics
Product Components
|
Product Applications
Diagnosis of congenital or acquired Factor VIII:C deficiencies (Haemophilia A).
Assay of Factor VIII:C activity, in citrated human plasma or in therapeutic concentrates, where Factor
VIII:C activity must be measured.
Follow-up of Factor VIII:C recovery in treated patients.
Associated calibrator and controls are available: BIOPHEN™ Plasma Calibrator (Ref A222101-CAN), BIOPHEN™ Normal Control Plasma
(Ref A223201-CAN) and BIOPHEN™ Abnormal Control Plasma (Ref A223301-CAN). Please Note: IVD Not for Sale in US. For US availability CLICK HERE.
Material Safety Data Sheet (MSDS)Certificate of Analysis (COA) |